Dermavant Sciences Announces Closing of Transaction With GSK for Purchase of Rights to Tapinarof
21. August 2018 16:00 ET
|
Dermavant Sciences, Inc.
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a subsidiary of Roivant Sciences, today announced the closing of its transaction with GSK, executed on July 10, 2018, for the purchase...